Impact of Saccharomyces boulardii on acute gastrointestinal toxicities in patients undergoing pelvic radiotherapy for gynecologic cancers: a randomized controlled trial.
- 2025-06-17
- RCT · n = 60
- Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 33(7)
- Pooriwat Muangwong
- Ekkasit Tharavichitkul
- Parameth Thiennimitr
- Imjai Chitapanarux
- Kittikun Kittidachanan
- Taned Chitapanarux
- PubMed: 40526282
- DOI: 10.1007/s00520-025-09663-8
- High evidence
- Clinical
Overall, no significant differences were found between the groups in terms of cumulative GI toxicities
- Effect
- Neutral
- Effect size
- Small
- Significant
- No
- Dose
- 250 mg/day